Anders Mørkeberg Hinsby,Thomas Kirkegaard Jensen,Gert Mads Bolwig,Carlos Roberto Camozzi
申请号：
US16826733
公开号：
US20200261437A1
申请日:
2020.03.23
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical formulation which provides for extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers and the acid addition salts thereof.
